Ask a question
How is CD34 used in the assessment of bone marrow health?
CD34 is employed as a marker to evaluate the status of bone marrow, aiding in the diagnosis and monitoring of disorders affecting the bone marrow.
How does CD34 impact the prognosis of hematologic diseases?
CD34 expression levels are sometimes correlated with the prognosis of certain hematologic diseases, helping clinicians predict disease outcomes and plan appropriate interventions.
How does CD34 contribute to the understanding of hematologic malignancies?
CD34 expression patterns are studied to gain insights into the pathogenesis and progression of hematologic malignancies, aiding in the development of targeted therapies.
Can CD34 be used to monitor the effectiveness of cancer treatments?
Yes, changes in CD34 expression can be indicative of the response to cancer treatments, providing valuable information for patient management.
Are there any specific therapeutic applications of CD34?
CD34 is a target for therapeutic interventions, and research is ongoing to explore its potential for developing treatments for various diseases.
Is CD34 exclusively used in hematological research, or does it have applications in other medical fields?
While CD34 is prominently used in hematological research, its role in angiogenesis extends its applications to cardiovascular research and regenerative medicine.